hC Bioscience to Present at Locust Walk RNA Innovation Conference

May 02, 2023
Cambridge, MA

hC Bioscience (Private) announced that Leslie Williams, president and CEO, will deliver a presentation on the science behind tRNA-based therapies and the company’s therapeutic programs at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 11:00 a.m. ET.

The Locust Walk RNA Innovation Conference is hosted in partnership with Dr. Frank Slack, Director of the Beth Israel RNA Medicine Initiative, and Dr. Phil Zamore, Director of the UMass Chan RNA Medicine Institute. Locust Walk is hosting a virtual one-day investor and partner conference exploring innovations in RNA research and development, including:

  • Protein Expression
  • RNA Editing
  • RNA-Mediated Protein & Transcriptome Regulation
  • RNA Targeting SMOLs​
  • Translation Inhibition
  • Novel Delivery Approaches

The event will showcase cutting-edge science, industry trends, and high-value opportunities in next-generation in RNA R&D. The format will include keynote speakers, company presentations, and panel discussions featuring leaders and luminaries from industry, academia, and the investment community.